CoChat

Exome sequencing and characterization of 49,960 individuals in the UK Biobank

Open access

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Abstract

The UK Biobank is a prospective study of 502,543 individuals, combining extensive phenotypic and genotypic data with streamlined access for researchers around the world 1 . Here we describe the release of exome-sequence data for the first 49,960 study participants, revealing approximately 4 million coding variants (of which around 98.6% have a frequency of less than 1%). The data include 198,269 autosomal predicted loss-of-function (LOF) variants, a more than 14-fold increase compared to the imputed sequence. Nearly all genes (more than 97%) had at least one carrier with a LOF variant, and most genes (more than 69%) had at least ten carriers with a LOF variant. We illustrate the power of characterizing LOF variants in this population through association analyses across 1,730 phenotypes. In addition to replicating established associations, we found novel LOF variants with large effects on disease traits, including PIEZO1 on varicose veins, COL6A1 on corneal resistance, MEPE on bone density, and IQGAP2 and GMPR on blood cell traits. We further demonstrate the value of exome sequencing by surveying the prevalence of pathogenic variants of clinical importance, and show that 2% of this population has a medically actionable variant. Furthermore, we characterize the penetrance of cancer in carriers of pathogenic BRCA1 and BRCA2 variants. Exome sequences from the first 49,960 participants highlight the promise of genome sequencing in large population-based studies and are now accessible to the scientific community.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2853-0

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Predicted number of genes in carriers of heterozygous LOF variants in around 500,000 whole-exome sequences from existing WES data. The number of autosomal genes with at least 1, 5, 10, and so on, carriers of heterozygous LOF variants that passed Goldilocks quality control (see Supplementary Methods), had genotype missingness of <10% and Hardy–Weinberg equilibrium P > 10−15 increases with sample size. UKB participants of European ancestry with WES data (n = 46,911) were downsampled at random to the number of individuals specified on the x axis. The number of genes containing at least the indicated count of carriers of heterozygous LOF variants with MAF < 1% as indicated in the legend are plotted on the y axis. The number of autosomal genes is 18,574 in this gene model. The blue dashed line indicates the predicted number of genes (18,273) with at least 1 carrier of a heterozygous LOF variant in 500,000 exomes. Solid curves connect the observed number of genes; dashed curves connect predicted counts from a β-binomial mixture model (see Supplementary Methods).
Fig. 1 Predicted number of genes in carriers of heterozygous LOF variants in around 500,000 whole-exome sequences from existing WES data. The number of autosomal genes with at least 1, 5, 10, and so on, carriers of heterozygous LOF variants that passed Goldilocks quality control (see Supplementary Methods), had genotype missingness of <10% and Hardy–Weinberg equilibrium P > 10−15 increases with sample size. UKB participants of European ancestry with WES data (n = 46,911) were downsampled at random to the number of individuals specified on the x axis. The number of genes containing at least the indicated count of carriers of heterozygous LOF variants with MAF < 1% as indicated in the legend are plotted on the y axis. The number of autosomal genes is 18,574 in this gene model. The blue dashed line indicates the predicted number of genes (18,273) with at least 1 carrier of a heterozygous LOF variant in 500,000 exomes. Solid curves connect the observed number of genes; dashed curves connect predicted counts from a β-binomial mixture model (see Supplementary Methods).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Cited by

See all 619

Metadata

Authors
Van Hout, C. V., Tachmazidou, I., Backman, J. D., Hoffman, J. D., Liu, D., Pandey, A. K., Gonzaga-Jauregui, C., Khalid, S., Ye, B., Banerjee, N., Li, A. H., O’Dushlaine, C., Marcketta, A., Staples, J., Schurmann, C., Hawes, A., Maxwell, E., Barnard, L., Lopez, A., Penn, J., Habegger, L., Blumenfeld, A. L., Bai, X., O’Keeffe, S., Yadav, A., Praveen, K., Jones, M., Salerno, W. J., Chung, W. K., Surakka, I., Willer, C. J., Hveem, K., Leader, J. B., Carey, D. J., Ledbetter, D. H., Geisinger-Regeneron DiscovEHR Collaboration, Cardon, L., Yancopoulos, G. D., Economides, A., Coppola, G., Shuldiner, A. R., Balasubramanian, S., Cantor, M., Regeneron Genetics Center, Nelson, M. R., Whittaker, J., Reid, J. G., Marchini, J., Overton, J. D., Scott, R. A., Abecasis, G. R., Yerges-Armstrong, L., & Baras, A.
Affiliations
  • AstraZeneca (United Kingdom) (GB)
  • Regeneron (United States) (US)
  • GlaxoSmithKline (United States) (US)
  • Hasso Plattner Institute (DE)
  • Columbia University Irving Medical Center (US)
  • University of Michigan (US)
  • Norwegian University of Science and Technology (NO)
  • GlaxoSmithKline (United Kingdom) (GB)
  • Deerfield (United States) (US)
Corresponding author
  • Scott, Robert A.
  • Yerges-Armstrong, Laura
  • Baras, Aris
Venue
Nature
Published
2020-10-21
Volume
586
Issue
7831
Pages
749-756
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W3094550675
Cited by
561
References
59
Citations by year
2026: 42 · 2025: 74 · 2024: 95 · 2023: 97 · 2022: 115 · 2021: 95 · 2020: 32
FWCI
49.70
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • publish.UP (University of Potsdam) (submittedVersion, cc-by)
Funders
  • Norges Teknisk-Naturvitenskapelige Universitet
  • Norwegian Institute of Public Health
  • National Heart, Lung, and Blood Institute (R01HL109946)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
exome sequencing, UK Biobank, loss-of-function mutations, coding variants, genetic association, Piezo1, varicose veins, COL6A1, MEPE, bone mineral density, IQGAP2, blood cell traits, pathogenic variants, BRCA1, BRCA2, cancer penetrance, population genomics
MeSH terms
Exome Sequencing, Loss of Function Mutation, Aged, Demography, Female, Genotype, United Kingdom, Humans, Ion Channels, Male, Middle Aged, Neoplasms, Peptide Fragments, Phenotype, Varicose Veins, Bone Density, Genes, BRCA1, Penetrance, ras GTPase-Activating Proteins, Collagen Type VI, Genes, BRCA2, Databases, Genetic, Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exome sequencing and characterization of 49,960 individuals in the UK Biobank. https://app.cochat.ai/papers/10.1038/s41586-020-2853-0
The paper
Van Hout, C. V., Tachmazidou, I., Backman, J. D., Hoffman, J. D., Liu, D., Pandey, A. K., Gonzaga-Jauregui, C., Khalid, S., Ye, B., Banerjee, N., Li, A. H., O’Dushlaine, C., Marcketta, A., Staples, J., Schurmann, C., Hawes, A., Maxwell, E., Barnard, L., Lopez, A., . . . Baras, A. (2020). Exome sequencing and characterization of 49,960 individuals in the UK Biobank. Nature. https://doi.org/10.1038/s41586-020-2853-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.